Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Evolving role of HER2 targeted therapies in gastroesophageal cancers

Barbara Burtness, MD, of Yale Cancer Center, New Haven, CT, discusses advancements in targeting HER2 for the treatment of gastroesophageal cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).